Ebt Mobile (EBT) Quote

Waiting for the 3rd cohort news results!!!can be life changing

IBM
IBM price target raised to $233 from $227 at JPMorgan
JPMorgan raised the firm's price target on IBM to $233 from $227 and keeps a Neutral rating on the shares as part of a Q4 earnings preview. The firm expects "healthy" software and artificial intelligence business for Q4, offs

good morning 🌞🌞🌞🌞🌞🌞🌞🌞🌞🌞🌞

still hard to believe? how about when it hits $0.50ike you have been around log enough to know anything is possible with tmmi. I feel from what AI and fractal compression can accomplish, we are looking again at PPS hitting a buck. This could all happen before July of this year. merge Timmy with an e

Nice call Sickzone, The new business license is another step closer to first sales!!

“As for upcoming pr I expect Kim will pr the business license received this week in lam dong for Prodigy Silk .
.”

Our Father in heaven,
Hallowed be Your name.
Your kingdom come.
Your will be done
On earth as it is in heaven.
Give us this day our daily bread.
And forgive us our debts,
As we forgive our debtors.
And do not lead us into temptation,

Oh heck yeah. Big changes to the mobile version.

Version 7.0 is the best yet!  

Mods, please pin up yesterday's news. TIA

-
https://t.co/bjG3OVKhaN Investor Deck

https://investorshub.advfn.com/uimage/uploads/2025/1/23/bjycjGh8IgxLXcAAyPi-.jpg

Yeah - .0035 all in huh? For your sake I hope it blows by that in 2025 and you recoup your money. I now understand your frustration as my average is trip 6 and I can step out anytime... GLTY Ice.

What does the short report say about yesterday's trading????🙄

You missed the entire point . With the amount of money that has been paid to cognate and advent over last decade , why couldn't that capability be built under NWBO ownership ? 
- why was cognate being paid for "readiness" years and years ago ??? 

Sick!   Site is becoming more and more robust!  

https://www.hcdnnj.org/tax-foreclosure-and-tax-sales

(edit) our guys need to get busy over at DPW. 53 players a pretty good turnout though.

But tougher to win now, with so much competition. Even with the LIV players pulling some of the better players out.

Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks

https://finance.yahoo.com/news/iovance-biotherapeutics-iova-among-billionaire-201009995.html

Woo Hoo. 26° ! ! ! That's great.
I'll take that over our 5.
Bask in the warmth of winter.
You're a lucky man.

17° Yipe. That's way too cold for your area.
Be careful on the roads.
Remember... if they look wet, that's probably black ice.
And... bridges freeze before the rest of the road.

Please let us know how it went when you get back.
Good luck.

This 🗑️Defines that STICKY Perfectly.

I JUST emailed Dianne and told her to tell Nasrat that shareholders are expecting/would like to see a press release similar to the one below:

January 28, 2013

Elite Pharmaceuticals, Inc. Announces First Shipments From Expanded 15,000 Square Foot Facility